Literature DB >> 2567030

Chronic neuroleptic effects on spatial reversal learning in monkeys.

E D Levin1, L M Gunne.   

Abstract

Cebus apella monkeys were chronically administered the antipsychotic drug fluphenazine decanoate for periods ranging from 3.5 to 5.5 years. In the present study, four of these monkeys and two controls were tested for cognitive abilities on a spatial learning task, which consisted of an original discrimination and four reversals of that discrimination. No effect of fluphenazine administration was seen in the rate of learning the original discrimination, but the carryover of learning across discrimination reversals was significantly reduced by fluphenazine. After overtraining on the original discrimination, the controls showed the normal difficulty in learning the first reversal. The fluphenazine-treated monkeys showed no such disruption. On subsequent reversals, the controls showed continually improving performance, so that on the third and fourth reversals they had near-perfect scores. On the other hand, the fluphenazine-treated monkeys showed no change over the four reversals. Unlike normal monkeys, their learning did not improve with practice. Although simple forms of learning seem to be relatively unaffected by chronic fluphenazine administration, more complex learning is disrupted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567030     DOI: 10.1007/BF00439554

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Schizophrenics with tardive dyskinesia. Neuropsychological deficit and family psychopathology.

Authors:  J T Wegner; F Catalano; J Gibralter; J M Kane
Journal:  Arch Gen Psychiatry       Date:  1985-09

2.  Cognitive impairment in tardive dyskinesia.

Authors:  J T Wegner; J M Kane; P Weinhold; M Woerner; B Kinon; J Lieberman
Journal:  Psychiatry Res       Date:  1985-12       Impact factor: 3.222

3.  Span of apprehension deficits during the postpsychotic stages of schizophrenia. A replication and extension.

Authors:  R F Asarnow; D J MacCrimmon
Journal:  Arch Gen Psychiatry       Date:  1981-09

4.  Spatial working memory in rats: effects of monoaminergic antagonists.

Authors:  W W Beatty; J R Rush
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

5.  Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

Authors:  L M Gunne; J E Häggström; B Sjöquist
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

6.  Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.

Authors:  J L Waddington; H A Youssef; C Dolphin; A Kinsella
Journal:  Arch Gen Psychiatry       Date:  1987-10

7.  The effects of neuroleptics on attention in adolescent schizophrenics.

Authors:  W D Erickson; A M Yellin; J H Hopwood; G M Realmuto; L M Greenberg
Journal:  Biol Psychiatry       Date:  1984-05       Impact factor: 13.382

8.  Chronic haloperidol effects on oral movements and radial-arm maze performance in rats.

Authors:  E D Levin; D M Galen; G D Ellison
Journal:  Pharmacol Biochem Behav       Date:  1987-01       Impact factor: 3.533

9.  Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

Authors:  J L Waddington; H A Youssef; A G Molloy; K M O'Boyle; M T Pugh
Journal:  J Clin Psychiatry       Date:  1985-04       Impact factor: 4.384

10.  An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.

Authors:  J L Waddington; H A Youssef
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  2 in total

Review 1.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.

Authors:  Raquel Cristine Silva Barcelos; Dalila Moter Benvegnú; Nardeli Boufleur; Patrícia Reckziegel; Liz Girardi Müller; Camila Pase; Tatiana Emanuelli; Marilise Escobar Bürger
Journal:  Neurotox Res       Date:  2009-07-31       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.